NCT05465954 2026-01-12Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent GlioblastomaMayo ClinicPhase 2 Recruiting54 enrolled
NCT03687957 2025-11-25rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and TemozolomideWashington University School of MedicinePhase 1/2 Active not recruiting42 enrolled 19 charts